DECEMBER 10, 2016::

AvantBio’s (AvantFluor’s) patent application regarding its new Sulfur Pentafluorobromide (SF5Br) production process has recently been granted in Canada, in addition to Japan, South Korea, China, the Russian Federation, Mexico, Australia and South Africa. AvantBio (AvantFluor)  anticipates patent allowances in the European Federation, the United States and India as well.  With the addition of Canada to the list of patent-protected jurisdictions, AvantBio (AvantFluor)  can now operate in both the Asian and some of the North American markets. It is expected that AvantBio’s new Sulfur Fluoride production processes may significantly reduce the cost of bringing  AvantBio’s “C-F” (SF4) and “C-SF5” (SF5Cl, SF5Br) fluorinating reagents into the marketplace. With the advent of less costly and more routinely available SF5Cl and SF5Br, less costly downstream aliphatic R-SF5  derivatives are also expected to become more readily-available  as well.  (click here for more information and business development opportunities).